In vivo Bioluminescent Imaging of Mammary Tumors Using IVIS Spectrum

Overview

This study demonstrates a non-invasive method for monitoring tumor growth in mice using bioluminescence. Mammary tumor cells expressing luciferase are implanted subcutaneously, allowing for real-time imaging of tumor development.

Key Study Components

Area of Science

• Oncology
• Imaging Techniques
• Bioluminescence

Background

• Luciferase is a widely used marker for tracking tumor growth.
• Non-invasive imaging techniques are essential for longitudinal studies.
• Monitoring tumor development can aid in evaluating treatment efficacy.
• Using a murine model provides insights into cancer biology.

Purpose of Study

• To establish a protocol for monitoring tumor growth using bioluminescence.
• To evaluate the effectiveness of luciferase-expressing tumor cells in imaging studies.
• To provide a framework for future cancer research and drug testing.

Methods Used

• Thawing and culturing luciferase-expressing mammary tumor cells.
• Injecting tumor cells subcutaneously into immunocompromised mice.
• Administering luciferin for bioluminescent imaging.
• Using an imaging system to capture and analyze luminescent signals.

Main Results

• Bioluminescence correlates with tumor size over time.
• Imaging can detect tumors as early as 10 minutes post-injection.
• Longitudinal studies show tumor growth dynamics over weeks.
• Necrosis observed in tumors after 28 days, indicating treatment effects.

Conclusions

• The method provides a reliable approach for tracking tumor growth in vivo.
• Bioluminescence imaging is effective for assessing therapeutic interventions.
• This technique can enhance understanding of tumor biology and treatment responses.

Frequently Asked Questions